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Background: Severe traumatic knee injury, including injury to the anterior cruciate ligament (ACL), leads to
impaired sensorimotor function. Although improvements are achieved by training, impairment often persists.
Because good sensorimotor function is associated with better patient-reported function and a potential lower risk
of future joint problems, more effective treatment is warranted. Temporary cutaneous anesthesia of adjacent body
parts was successfully used on the hand and foot to improve sensorimotor function. The aim of this study was to
test whether this principle of brain plasticity could be used on the knee. The hypothesis was that temporary
anesthesia of the skin area above and below the knee would improve sensorimotor function of the ipsilateral knee
and leg in subjects with ACL injury.
Methods: In this double-blind exploratory study, 39 subjects with ACL injury (mean age 24 years, SD 5.2, 49% women,
mean 52 weeks after injury or reconstruction) and self-reported functional limitations and lack of trust in the knee were
randomized to temporary local cutaneous application of anesthetic (EMLAW) (n = 20) or placebo cream (n=19). Fifty
grams of EMLAW, or placebo, was applied on the leg 10 cm above and 10 cm below the center of patella, leaving the
area around the knee without cream. Measures of sensory function (perception of touch, vibration sense, knee
kinesthesia) and motor function (knee muscle strength, hop test) were assessed before and after 90 minutes of treatment
with EMLAW or placebo. The paired t-test was used for comparisons within groups and analysis of variance between
groups, except for ordinal data where the Wilcoxon signed rank test, or Mann–Whitney test, was used. The number of
subjects needed was determined by an a priori sample size calculation.
Results: No statistically significant or clinically relevant differences were seen over time (before vs. after) in the measures
of sensory or motor functions in the EMLAW group or in the placebo group. There were no differences between the
groups due to treatment effect (EMLAW vs. placebo).
Conclusions: Temporary cutaneous anesthesia of adjacent body parts had no effect in improving sensorimotor function
of the knee and leg in subjects with severe traumatic knee ligament injury.* Correspondence: eva.ageberg@med.lu.se
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Severe traumatic knee injury, including injury to the anter-
ior cruciate ligament (ACL), leads to impaired sensori-
motor function. This is observed as, for example,
proprioceptive deficiency, and reduced muscle strength
and functional performance [1]. Although improvements
are achieved by training interventions [2-4], impairment
often persists despite such treatment [5]. Also, the
achieved improvements are evident in measures of motor
function (muscle strength, functional performance), but
the possible influence of training on sensory function
(proprioceptive acuity) remains uncertain [3,4,6]. The im-
portance of sensorimotor function is reflected by its asso-
ciation with the patient’s perceived knee-related function
and quality of life [7-9], and its potential protective role
for detrimental long-term consequences, such as osteo-
arthritis (OA) [10-12]. From this perspective, treatment
resulting in improved sensorimotor function would be of
value for patients with knee injury and OA in the short
and long term.
The primary motor (M1) and sensory (S1) cortex is
organized somatotopically, where different body parts
project to different parts of the M1 and S1. The somato-
topic map does not represent the body in its actual pro-
portions [13,14]. Instead, larger cortical areas are being
assigned to sensitive parts or parts with complex motor
demands such as the hands and face [15,16]. It is well
known from animal and human experiments that tem-
porary cutaneous anesthesia of one body part leads to
cortical re-organization resulting in a corresponding si-
lent area in the sensory cortex. This allows adjacent
nearby body parts in the primary somatosensory cortex
to rapidly expand at the expense of the silent cortical
area [17,18]. This phenomenon, i.e., the manner in
which the nervous system can modify its organization
and ultimately its function [19,20], is often referred to as
brain plasticity [21,22].
The ability of the central nervous systems (CNS) to
change can also be used for therapeutic purposes, i.e.,
targeted plasticity [23] where weakened or lost functions
can be strengthened. In healthy persons as well as in
patients with median or ulnar nerve injuries, cutaneous
anesthesia of the forearm has been shown to rapidly im-
prove sensory function in the hand. The principle of
temporary cutaneous anesthesia of adjacent body parts
in combination with training was more effective in im-
proving sensory function of the hand than training only
[24,25]. The rapid improvement of sensory function and
the enhanced effects 4 weeks after the last local
anesthesia treatment [24,26], indicates that this interven-
tion is clinically useful and relevant. Hypothetically, this
principle could also be used to improve sensorimotor
function of the knee. The ACL-injured knee may consti-
tute a suitable model for this approach, because thisperipheral musculoskeletal injury may also be regarded
as a neurophysiological dysfunction [27,28]. An advan-
tage is that the selective cutaneous anesthesia does not
affect motor function of the leg, which means that the
individual can use the leg during training while the skin
is anesthetized.
In this study, we hypothesized that temporary anesthesia
of the skin area above and below the knee would improve
sensorimotor function of the ipsilateral knee and leg in
subjects with severe traumatic knee ligament injury and
self-reported functional limitations.
Methods
Subjects and randomization
Thirty-nine (19 women) subjects with ACL injury were
included in this exploratory double-blind RCT. Inclusion
criteria were: i) 18 to 35 years, ii) ongoing post-injury/
post-surgery training, iii) ≥ 10 weeks after ACL injury,
or ≥ 16 weeks after ACL reconstruction, iv) ability to per-
form a single-limb hop, v) self-reported functional lim-
itations. Functional limitations were determined as knee-
related problems in physical function and/or quality of
life in at least 2 of 4 questions in the Knee injury and
Osteoarthritis Outcome Score (KOOS) as follows: 1) at
least moderate difficulty in jumping (subscale sport and
recreation function, question 3); 2) at least moderate dif-
ficulty in twisting/pivoting on the injured knee (subscale
sport and recreation function, question 4); 3) at least
moderate trouble with lack of confidence in the knee
(subscale quality of life, question 3); 4) at least moderate
difficulty with the knee in general (subscale quality of
life, question 4). Exclusion criteria were a history of
other major orthopedic lesions, such as previous knee
injury or fracture, and allergic reactions to anesthetic
agents. The patients were enrolled at a sports physical
therapy clinic by the test leader. They all had neuromus-
cular training [1,29], supervised by either of eight phys-
ical therapists at this clinic. Subject characteristics,
including activity level [30] and self-reported outcomes
assessed by the Knee injury and Osteoarthritis Outcome
Score (KOOS) [31,32], are given in Table 1.
The subjects were randomly allocated, using a random
number generator, to temporary anesthesia using a local
anesthetic cream, EMLAW, (EMLAW group) or a placebo
cream (oil and water emulsion) (placebo group). To en-
sure an equal number of men and women in each group
two computer-generated randomization lists, one for
women and one for men, were drawn up by a biostatisti-
cian and given to the assessor. The assessor allocated
the next available number on entry into the trial, assign-
ing the subjects to treatment/placebo. The Research
Ethics committee of Lund University approved the study
(LU 107/2007), and all subjects gave their written
informed consent.
Table 1 Characteristics of the subjects
Characteristic EMLA group
(n = 20)
Placebo group
(n = 19)
Age (y)* 25 (5.6) 23 (4.9)
Women (n) 10 9
BMI* 23.7 (3.1) 24.3 (2.9)
ACL injury (ACL reconstruction) (n) 6 (14) 9 (10)
Time after ACL injury or ACL
reconstruction (weeks){
54 (17–315) 48 (10–243)
Previous contralateral
ACL injury/reconstruction (n)
2 2
Tegner activity level† 2 (2–4) 4 (2–6)
KOOS subscales*
Pain 82 (10.8) 78 (12.2)
Symptoms 74 (12.0) 72 (14.3)
ADL 90 (8.6) 90 (10.4)
Sport/Rec 47 (20.9) 47 (24.7)
QOL 41 (12.4) 40 (10.5)
* Mean (SD), † median (quartiles), { mean (range), BMI; body mass index.
ACL reconstruction: hamstring tendons graft, n = 23, patellar tendon graft,
n = 1.
The Tegner Activity Scale, ranges from 0 to 10, least to hardest strenuous
activity for the knee. A Tegner activity level of 2 is equal to recreational sports
such as golf, cycling and swimming, an activity level of 4 is equal to
recreational sports such as jogging, aerobics, or cross-country skiing and a
Tegner activity level of 6 is equal to recreational sports such as tennis or
badminton and competitive sports such as orienteering.
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Twenty subjects received a local anesthetic cream contain-
ing 2.5% lidocaine and 2.5% prilocaine (EMLAW, AstraZe-
neca, Södertälje, Sweden) and 19 subjects received a
placebo cream of an oil and water emulsion (DAX, Opus
Health Care Inc., Malmö, Sweden). The two creams were
identical in color, consistency and packaging. A staff mem-
ber, not participating as an assessor or subject in the study,
distributed the packages with cream to the assessor. Fifty
grams of EMLAW, or placebo [33], was applied circumfer-
entially on the leg 10 cm above and 10 cm below the center
of patella, leaving the area around the knee without cream
(Figure 1) [34]. The skin areas where the EMLAW/placeboFigure 1 Application of local anesthetic or placebo cream. EMLA, or p
of patella, leaving the area around the knee without cream.was applied were covered with film wrap and a TubigripW
stocking (MEDLOCK Medical, Oldham, UK). After 90
minutes, during which time the subject was seated, the
EMLAW/placebo was carefully washed off. The test leader
and the subjects were blinded to group allocation, and the
subjects were told not to reveal any possible anesthetic sen-
sation. Therefore, the presence or absence of anesthesia in
the area where the EMLAW/placebo was applied was not
verified by the assessor or the subject. The success of blind-
ing related to cream was not evaluated.
Outcome measures
Measures of sensory and motor functions were assessed
before and after 90 minutes of treatment with EMLAW
or placebo according to the protocol of our previous
study [34]. The tests were performed in the order that
they are described below. EMLAW/placebo was applied
and all tests were performed on the injured leg only
(in those four with a previous contralateral knee injury,
the recently injured leg was tested). An experienced as-
sessor, who received explicit guidelines and thorough
training and pilot-testing prior to study start, performed
the measurements.
Measures of sensory function
Three measures of sensory function were used; perception
of touch, vibration sense and knee kinesthesia. Lower
values in these tests indicate better sensory function.
Perception of touch Semmes-Weinstein monofilaments
(SWM) were used for assessing perception of touch at
the most prominent point of the medial and lateral
femoral condyles, just proximal of the joint space (areas
where no cream was applied). In our previous study, one
site (the medial femoral condyle) was assessed only [34].
Because a ceiling effect was found in that study [34], two
sites were included in the current study. Prior to the
test, the SWM (nr 4.31, 2.0 g) was demonstrated on the
patient’s styloid process of the hand, so that the subjects
could familiarize themselves with the test. Thereafter,lacebo, applied on the leg 10 cm above and 10 cm below the center
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close their eyes, concentrate on their knee and respond
when they felt any sensation of touch. The assessment
was performed according to a standardized procedure
[35]. Each monofilament, starting with the thinnest and
continuing with thicker until response to sensation, was
applied perpendicular to the skin for 1.5 seconds and
lifted for 1.5 seconds. The filament was applied 3 times
to the same spot and was bent each time to exert the
specific pressure. Feeling the monofilament was
recorded when at least one out of three applications was
identified by the patient [35].
Vibratory perception threshold Vibratory perception
threshold (VPT) was assessed by a biothesiometer (Bio-
Medical Instrument, Newbury, OH, USA), as described
[34]. Prior to the test, the Biothesiometer was demon-
strated on the patient’s ulna styloid process, so that the
subjects could familiarize themselves with the test.
Thereafter, the subjects lay in a supine position and were
asked to close their eyes, concentrate on their foot/knee
and respond when they felt any sensation of vibration.
The biothesiometer tip was held with uniform pressure
at two sites: the most prominent point of the medial
malleolus and the medial femoral condyle (same location
as that for testing perception of touch). Three consecu-
tive measurements were taken on each site, and the
amplitude was replaced to zero between each measure-
ment without moving the biothesiometer tip from the
location. The amplitude was increased by 1 Volt per sec-
ond until the subjects responded to a sensation of vibra-
tion. This was noted as the VPT. The first measurement
was regarded a trial test, and was, thus, excluded from
the analysis. If the difference between the second and
third measurement was more than 20%, 2 additional
tests were taken. The mean of the second and third, or
fourth and fifth, measurements was used in the analysis.
High reliability has been reported for the biothesiometer
[36,37]. Vibration data for the patients and controls was
reported previously [38].
Knee kinesthesia Kinesthesia was measured in a specif-
ically designed apparatus, which has been used and
described in detail in previous studies [39,40]. The sub-
jects lay in a lateral decubitus position, were asked to
close their eyes, concentrate on their knee and respond
when they felt any sensation of movement in their knee.
Measurements of the threshold for detection of passive
motion (TDPM) were performed towards knee extension
(TE) and knee flexion (TF) from the starting position of
20° knee joint flexion, giving the variables TE20 and
TF20. The median values of three consecutive measure-
ments of these two variables were determined. The vari-
ables from the 20° starting position (TE20 and TF20)have been found to be reliable in uninjured subjects
[41]. The sum of TE20 and TF20, giving an index value,
was used for statistical analysis.
Measures of motor function
Two measures of motor function were used; the one-leg
hop test for distance and knee extensor muscle power.
Higher values in these tests indicate better motor
function.
One-leg hop test for distance The one-leg hop test for
distance with the arms free, aiming at a more functional
execution of the hop, was used. The one-leg hop test is
widely used for predicting functional knee stability
[1,42]. Muscle strength, balance and confidence in the
knee are contributing factors to the performance of this
test. The subjects were told to hop as far as possible,
taking off and landing on the same foot, maintaining
their balance for about 2–3 seconds. The test was per-
formed three times, the hop distance being measured
(in cm) from toe in the starting position to heel in the
landing position. If the subject improved more than
10 cm between the second and third hop, additional
hops were performed until an increase of less than
10 cm was measured. A trial one-leg hop preceded the
measurements. The subjects wore shoes, e.g., sneakers.
The mean value of the three best hops was used in the
analysis. The reliability of this test is high in subjects
with ACL injury [43].
Knee extension power The muscle strength test was
performed as described, with standardized verbal
instructions and encouragement [5,44]. The subject was
seated, using an individual seating position, in a knee ex-
tension weight training machine (Precor, Icarian, Borås,
Sweden). The test was performed with the injured leg,
and the other leg was fixed in place using a strap. Before
the strength test, the subjects completed ten repetitions
at a sub-maximum weight, followed by five repetitions
using a somewhat higher sub-maximum weight. The
subject then performed a single repetition, of approxi-
mately 90% of their maximum, to select the appropriate
starting weight.
On a given signal, the subject was asked to extend his/
her knee as quickly and forcefully as possible from ap-
proximately 110o of knee flexion to full knee extension
(0o of flexion). The distance the weight stack was lifted
and the time it took to fully extend the knee was mea-
sured with a linear encoder connected to the weight
stack of the machine. In all, the subjects performed five
maximum trials at five weight levels, until a decrease in
power was seen. The weight was increased by 5 kg for
each trial. The rest period between trials was 30 s, which
was considered to be sufficient for full recovery. The
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terised muscle function measuring system (Ergotest
Technology, Oslo, Norway). If a subject reported pain in
the knee during a test, which occurred in a few cases,
this particular test was cancelled and the measurement
was repeated. Data was missing for 2 patients (1 patient
did not perform the test because of knee pain, and too
few accurate values to calculate average power for 1
patient). Average power (W) was used in the analysis.
Statistical analysis
The number of subjects needed was determined by an a
priori sample size calculation from our previous study
[34]. No primary outcome measure was determined,
since the study has an exploratory character. We
expected to find an improvement in more than one of
the variables to interpret the results as an effect from
treatment. For knee kinesthesia, sample size calculations
revealed that at least 12 subjects were needed to detect
an improvement by treatment of 30% within groups
(SDdiff 0.49), with 80% power at the 5% significance level.
For vibration sense, 13 subjects were needed to detect
an improvement of 20% (SDdiff 3.3) within groups. For
the one-leg hop test, and knee extension power, less than
10 subjects were needed to detect an improvement by
treatment of 10% within groups, with 80% power at the
5% significance level. Based on these sample-size calcu-
lations, we included 40 subjects. The paired t-test was
used for comparisons within groups and analysis ofTable 2 Results for outcomes of sensory and motor functions
EMLA group (n= 20)
Before After
Mean (SE) Mean (SE) Mean diff (95% CI)
(after minus before)
M
Sensory function
SWM med fem cond
(grams)†*
0.02
(0.008:0.02)
0.008
(0.008:0.02)
p= 0.430
(
SWM lat fem cond
(grams)†*
0.008
(0.008:0.02)
0.008
(0.008:0.02)
p= 0.442
(
VPT med mall (Volt) 9.2(0.6) 10.3(0.8) 1.1(0.4:1.8)
VPT med fem cond
(Volt)
15.5(1.27) 15.1(1.51) −0.4(−1.9:1.1)
TDPM (degrees) 2.69(0.33) 2.52(0.27) −0.16(−0.73:0.41)
Motor function
One-leg hop (cm) 79.2(12.4) 83.3(7.61) 4.0(−0.1:8.2)
Knee ext power (W)* 130.0(12.4) 139.5(14.0) 9.5(1.4:17.7) 1
SWM Semmes-Weinstein monofilaments, VPT vibration perception threshold, Med m
lateral femoral condyle, TDPM threshold for detection of passive motion, ext extens
† median (quartiles).
* Missing data 1 patient for SWM (placebo group) and 2 patients for knee ext powe
Mean and standard error (SE) and mean difference (95% CI) (after minus before) for
kinesthesia) and motor function (one-leg hop test, knee extension power) before an
minus placebo) between the EMLA and placebo groups (t-test). Median (quartiles) a
perception of touch (ordinal data).variance, adjusting the variables for activity level,
between groups. All variables had Shapiro-Wilk statistic
of >0.90, except knee kinesthesia and VPT at the medial
malleolus. Because some variables were not normally
distributed, the results were confirmed using non-
parametric statistics. Wilcoxon signed rank test, or
Mann–Whitney test, was used for ordinal data (percep-
tion of touch). Effect size was calculated by taking the
difference between the means before and after EMLAW/
placebo and dividing it by the SD of the same measure
before EMLAW/placebo [45]. An effect size of <0.50 was
considered small, 0.50 to 0.79 moderate, and ≥0.80 large
[45]. A level of p ≤ 0.05 was chosen to indicate statistical
significance. Group allocation was concealed to the per-
son analyzing the data, until the results were completed.
Results
There were no differences between the groups due to
treatment effect (EMLAW vs. placebo) (Table 2). No sta-
tistically significant or clinically relevant differences were
seen over time (before vs. after) in the measures of sen-
sory or motor functions in the EMLAW group or in the
placebo group.
Sensory function before and after treatment with EMLAW
or placebo
There were no differences between the groups in effects
of treatment for the measures of sensory function
(Table 2). The effect sizes were generally small in thein the EMLA and placebo groups
Placebo group (n = 19) EMLA vs. placebo
Before After
ean (SE) Mean (SE) Mean diff (95% CI)
(after minus before)
Mean diff (95% CI)
(EMLA minus placebo)
0.008
0.008:0.02)
0.008
(0.008:0.04)
p= 0.134 p= 0.276
0.008
0.008:0.04)
0.008
(0.008:0.03)
p= 0.505 p= 0.951
9.7(0.60) 10.2(0.68) 0.5(−0.1:1.1) 0.6(−0.4:1.5)
16.0(1.20) 15.5(1.22) −0.6(−2.4:1.3) 0.0(−2.4:2.4)
2.74(0.37) 2.84(0.54) 0.11(−1.0:1.27) −0.28(−1.57:1.01)
90.6(9.9) 100.0(9.7) 9.5(3.6:15.3) −6.4(−13.4:0.6)
56.9(15.4) 158.3(15.5) 1.5(−8.1:11.0) 6.9(−5.5:19.4)
all medial malleolus, Med fem cond medial femoral condyle, Lat fem cond
ion.
r (1 patient in each group).
the tests of sensory function (perception of touch, vibration sense,
d after treatment with EMLA/placebo, and mean difference (95% CI) (EMLA
nd p-value (Wilcoxon singed rank test, Mann–Whitney test) given for
Ageberg et al. BMC Musculoskeletal Disorders 2012, 13:68 Page 6 of 8
http://www.biomedcentral.com/1471-2474/13/68EMLAW group (between 0.08 and 0.44) and in the
placebo group (between 0.07 and 0.19, except for per-
ception of touch at the medial femoral condyle; effect
size 0.78). No differences were found before vs. after
treatment for perception of touch, vibration sense at the
medial femoral condyle, or TDPM in the EMLAW group.
A higher VPT at the medial malleolus, indicating poorer
vibration sense, was found after compared with before
treatment. No differences were found between assess-
ments (before vs. after) for perception of touch, vibra-
tion sense, or kinesthesia in the placebo group (Table 2).
Motor function before and after treatment with EMLAW or
placebo
There were no differences between the groups in effects
of treatment for the measures of motor function
(Table 2). The effect sizes were small in the EMLAW
group (one-leg hop test 0.11, knee extension power 0.18)
and in the placebo group (one-leg hop test 0.22, knee
extension power 0.02). The patients in the EMLAW
group had higher knee extension power, and the patients
in the placebo group jumped a longer distance, after
compared with before treatment (Table 2).
Discussion
The hypothesis of this exploratory RCT on principles of
brain plasticity in improving sensorimotor function of
the knee in subjects with severe traumatic knee ligament
injury was not confirmed. No effect was found of tem-
porary cutaneous anesthesia of the skin area above and
below the knee on sensorimotor function of the ipsilat-
eral knee and leg in these subjects.
The forearm is located next to the hand in the soma-
totopic map [13,14] and by anaesthetizing the forearm,
the cortical hand area can expand over the forearm area
[46]. Thus, more nerve cells can be available for the
hand, resulting in improved hand function. This
principle has been successfully used in subjects with or
without hand nerve injury [24,25,47], and was recently
also efficiently applied to the foot in subjects with or
without diabetes [33,48].
Diminished activation in several sensorimotor cortical
areas has been observed in subjects with ACL injury
compared with controls, indicating that the injury causes
re-organization of the central nervous system [28]. Con-
versely, it may be assumed that cortical re-organization
can be achieved by an efficient intervention. By assessing
sensory function in the knee, we indirectly assessed a
possible cortical re-organization. An improved sensory
function, as found in the hands following forearm
anesthesia [46], would indicate a cortical re-organization
with an expanded cortical knee area in subjects with
anesthetized leg areas. Although no such changes were
seen, this does not completely rule out cortical changesfollowing treatment. However, if cortical changes did
occur they were likely very subtle. This, in combination
with the fact that the knee normally has a very small
representation in the somatosensory cortex, makes is
difficult or perhaps even impossible in this case to detect
changes in the cortical knee area using neuroimaging
methods such as fMRI. With this in mind, and because
no effects were found in the sensorimotor function tests
in the present study or in a previous study in healthy
subjects [34], we decided not to perform fMRI because
the likelihood of finding an cortical expansion-difference
would be small.
Neurophysiologic mechanisms in the lower extremity
may also differ from those in the upper extremity. Large
overlaps in the sensorimotor activation have been shown
following movement of the knee, ankle and toes as
opposed to the fingers [27]. However, the same plasticity
mechanisms likely occur in both the upper and lower
extremity, thus making it possible to manipulate plasti-
city mechanisms also in the lower extremity in order to
improve sensorimotor function, such as that reported
for the foot [33,48].
Because this was an RCT with a blinded design, that
is, both the assessor and the subject were blinded to
group allocation, numbness in the area where the
EMLAW/placebo was applied (see Figure 1) was not veri-
fied. However, the amount of EMLAW used (50 g) is a
dosage of active substance per cm2 well within the
recommendations to achieve cutaneous anesthesia.
The placing of the cream (above and below the knee)
is most likely adequate in order to expect an increased
cortical knee representation. Because the cortical area
devoted to the lower extremity is small compared to the
hand, we expected that a larger deafferented skin area
was needed (compared to the upper extremity) in order
to allow the knee to expand in the primary somatosen-
sory and motor cortex. Therefore, the EMLAW or pla-
cebo was applied circumferentially on the skin both
above and below the knee.
The effect sizes were generally small for all outcome
measures, indicating that the magnitude of change by
treatment was small. In previous studies on the hand
and foot, focus was on assessing improvements of tem-
porary anesthesia in sensory function (perception of
touch, vibration sense) [24,25,33,47,48], as these mea-
sures are relevant to the patient’s daily activities [24]. Be-
cause we applied this concept to the knee, these sensory
measures were included also in the present study. The
perception of touch of the knee is not as delicate, dis-
criminative or vital as in the hand or the foot sole.
Therefore, the relevance of this measure for patients
with knee injury, as used in the present study, may be
questioned. The first study evaluating vibration sense in
patients with ACL injury was recently reported [38].
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these patients compared with matched controls [38].
Perhaps a ceiling effect was present, limiting the chance
of improving perception of touch and/or vibration sense
in these patients by intervention using temporary
anesthesia.
Several studies have shown a deficiency in propriocep-
tive acuity (kinesthesia, joint position sense) in patients
with ACL injury; recently reported in a review [49].
While measures of motor function (muscle strength,
functional performance) appear relevant for patients
with knee injury [7-9], the association between sensory
function (proprioceptive acuity) and patient-reported
and motor functions is generally low [49]. For this rea-
son, the development of more accurate and precise
methods for assessing sensory function was proposed
[49]. Possibly, measures of motor function may be more
essential for activities of daily life and more demanding
activities than measures of sensory function for subjects
with knee injury. However, the possibilities of affecting
motor outcomes by temporary anesthesia may be more
difficult to achieve than for sensory outcomes [24].
The major strength of the current and previous [34]
studies is the design; the subjects were randomized to
anesthetic or placebo cream, the test leader was blinded
to group allocation, and group allocation was concealed
to the person analyzing the data until the results were
completed. However, from the results of the present and
previous [34] studies, temporary cutaneous anesthesia
was not a successful intervention to improve sensori-
motor function for patients with severe traumatic knee
ligament injury. The need for development and evalu-
ation of methods to improve the effects of treatment on
sensorimotor function after knee injury and knee OA
remains.
Conclusions
The principle of temporary cutaneous anesthesia of adja-
cent body parts had no effect in improving sensorimotor
function of the knee and leg in subjects with severe trau-
matic knee ligament injury.
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